Dihydrocodeine (Tartrate)
Overview
Categories
- 2 Analgesics, antipyretics, NSAIDs, antigout, and antirheumatics
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Tice-BCG's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 25 to 50 mg | 38 (37.5) | As recommended. | IV | After dental surgery |
| 0.286 to 0.857 mg/kg | 0.57 (0.5715) | 4 hourly | PO | As Required |
| 10 to 30 mg | 20 (20) | 8 hourly | PO | for cough suppression. |
| 50 mg | 50 (50) | 6 hourly | Scor IM | Max dose 240 mg daily. |
Paedriatic Dosage (20kg)
|
| 0.4 to 1.2 mg/kg | 0.8 (0.8) | 6 hourly | Oral | Recommended for 5-12 Yrs of Children |
| 0.5 to 1 mg/kg | 0.75 (0.75) | As recommended. | PO | for 4 to 6 hourly . Max 30mg |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Tice-BCG is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Tice-BCG
Back to top
Manufacturers of
Dihydrocodeine (Tartrate)
in Pakistan
Back to top
Previous Drug Generic - Next Drug Generic